Volume 92, Issue 7 pp. 1315-1322
Pediatric and Congenital Heart Disease

Premounted stents for branch pulmonary artery stenosis in children: A short term solution

Yinn Khurn Ooi MD

Yinn Khurn Ooi MD

Division of Cardiology, Children's Healthcare of Atlanta, Atlanta, Georgia

Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia

Search for more papers by this author
Sung In H. Kim MD, MPH

Sung In H. Kim MD, MPH

Emory University Rollins School of Public Health, Atlanta, Georgia

Search for more papers by this author
Scott E. Gillespie MS

Scott E. Gillespie MS

Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia

Search for more papers by this author
Dennis W. Kim MD, PHD

Dennis W. Kim MD, PHD

Division of Cardiology, Children's Healthcare of Atlanta, Atlanta, Georgia

Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia

Search for more papers by this author
Robert N. Vincent MD

Robert N. Vincent MD

Division of Cardiology, Children's Healthcare of Atlanta, Atlanta, Georgia

Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia

Search for more papers by this author
Christopher J. Petit MD

Corresponding Author

Christopher J. Petit MD

Division of Cardiology, Children's Healthcare of Atlanta, Atlanta, Georgia

Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia

Correspondence

Christopher J. Petit, MD, Emory University School of Medicine, Children's Healthcare of Atlanta, Division of Cardiology, 1405 Clifton Road NE, Atlanta, GA 30322.

Email: [email protected]

Search for more papers by this author
First published: 09 September 2018
Citations: 15

Abstract

Objective

Define outcomes of premounted stent implantation (PMS) for branch pulmonary artery stenosis (BPAS).

Background

PMS for BPAS in children raises concern of long term viability, with limited maximal expansion.

Methods

We reviewed our cardiac database over an 11-year period ending in 2013. Primary endpoint was need for surgical stent intervention (SSI). Other endpoints included acute results and repeat interventions (RI).

Results

82 PMS were implanted in 60 children for BPAS. Median weight was 6.3 (25th-75th 4.6–9.8) kg. Median stent diameter was 6 (range 4–9) mm. Acutely, vessel diameter improved from 2.0 (25th-75th 1.6–3.4) to 5.0 (25th-75th 4.2–5.9) mm (p < 0.001), pressure gradient decreased from 41 (25th-75th 29–50) to 11 (25th-75th 7–18) mmHg (n = 47, p < 0.001), RV:Ao pressure ratio decreased from 100% (25th-75th 85–110%) to 59% (25th-75th 49–74%) (n = 40, p < 0.001). Freedom from SSI was 81% at 1 year and 35% at 5 years. Freedom from RI was 50% at 1 year and 14% at 5 years. 86% of PMS underwent SSI during a concomitant planned cardiac surgery. 45% patients had stent redilation, improving stent diameter from 4.6 (25th-75th 4.1–5.4) to 5.7 (25th-75th 4.9–7) mm (p < 0.001). 1 stent (3%) was able to be fractured longitudinally.

Conclusions

PMS is an effective short term solution for BPAS in children. PMS is associated with expected early need for transcatheter reintervention to accommodate for growth, but also has high rates of SSI.

CONFLICT OF INTEREST

None

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.